|
|
Volumn 103, Issue 2, 2010, Pages 182-184
|
|
Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
ASPARTATE AMINOTRANSFERASE;
AZATHIOPRINE;
BILIRUBIN;
PYRIDOSTIGMINE;
ADD ON THERAPY;
AGED;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BILIRUBIN BLOOD LEVEL;
BLOOD TRANSFUSION;
CASE REPORT;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
DIGESTIVE SYSTEM FUNCTION DISORDER;
DISEASE COURSE;
DRUG WITHDRAWAL;
ERYTHROCYTE COUNT;
FEMALE;
FOLLOW UP;
HUMAN;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LEUKOCYTE COUNT;
LIMB WEAKNESS;
LIVER DYSFUNCTION;
LOW DRUG DOSE;
MASTICATION;
MYASTHENIA GRAVIS;
NERVE STIMULATION;
OSTEOPENIA;
PANCYTOPENIA;
PTOSIS;
RECURRENT DISEASE;
SIDE EFFECT;
THERAPY EFFECT;
THROMBOCYTE COUNT;
AGED;
AZATHIOPRINE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MYASTHENIA GRAVIS;
|
|
EID: 76949090688
PISSN: 00384348
EISSN: None
Source Type: Journal
DOI: 10.1097/SMJ.0b013e3181c81b93 Document Type: Letter |
|
Times cited : (2)
|
|
References (5)
|
